Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Quidelortho Corp (QDEL)

Quidelortho Corp (QDEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Quidelortho Corp 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 USA

www.quidelortho.com Employees: 7,100 P: 858-552-1100 F: 858-453-4338

Description:

QuidelOrtho is a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems. The company's brand names include Sofia(R), Solana(R), Lyra(R), Triage(R) and QuickVue(R). Its comprehensive product portfolio includes tests for a range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. QuidelOrtho, formerly known as Quidel Corporation, is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 2,699,696
Enterprise Value, $K 4,995,396
Shares Outstanding, K 67,257
Annual Sales, $ 2,998 M
Annual Net Income, $ -10,100 K
Last Quarter Sales, $ 727,100 K
Last Quarter Net Income, $ -19,900 K
EBIT, $ 130,200 K
EBITDA, $ 587,400 K
60-Month Beta 0.12
% of Insider Shareholders 1.00%
% of Institutional Shareholders 99.00%
Float, K 66,584
% Float 99.00%
Short Volume Ratio 0.44

Growth:

1-Year Return -41.84%
3-Year Return -72.28%
5-Year Return -41.50%
5-Year Revenue Growth 473.97%
5-Year Earnings Growth 46.45%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.85 on 11/07/24
Next Earnings Date N/A
Earnings Per Share ttm 2.31
EPS Growth vs. Prev Qtr 1,314.29%
EPS Growth vs. Prev Year -5.56%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

QDEL Ratios

Ratio
Price/Earnings ttm 16.40
Price/Earnings forward 21.86
Price/Earnings to Growth N/A
Return-on-Equity % 4.24%
Return-on-Assets % 2.17%
Profit Margin % -0.34%
Debt/Equity 0.80
Price/Sales 0.85
Price/Cash Flow 3.44
Price/Book 0.80
Book Value/Share 47.38
Interest Coverage -0.80
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar